Retatrutide's TRIUMPH-1 trial shows 28.3% average weight loss at 80 weeks
Medscape reports the top studied dose reached weight loss levels typically linked to bariatric surgery in Lilly's pivotal trial.
Recap by typeshit. Post by Medscape on X.
Medscape reports the top studied dose reached weight loss levels typically linked to bariatric surgery in Lilly's pivotal trial.
Recap by typeshit. Post by Medscape on X.
In mice, GLP-1 receptor signaling mainly calmed inflammation while GLP-2 receptor signaling helped the intestine repair after T cell attack, researchers report.
Talker Research polled 2,000 Americans for aesthetics company Revance. Of 1,402 GLP-1 users, over 24% reported a new identity shift after starting the drugs.
Raw numbers pointed to higher AMD risk with GLP-1 drugs, but researchers say the pattern reversed once heart and metabolic factors were accounted for.
The Havre de Grace center opened a research building and will test whether the pairing cuts alcohol cravings. The study starts in early 2027, results about two years later.
The Emirates Drug Establishment acted against 71 unapproved peptide sellers, 14 of them influencers, as Dubai put clinic peptides under strict rules.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
Loading…